NovaBridge Biosciences (NBP) Asset Utilization Ratio (2022 - 2023)
NovaBridge Biosciences (NBP) posted quarterly Asset Utilization Ratio of 0.01 for Q2 2023, down 14.36% on a QoQ basis from 0.01 in Q4 2022.
NovaBridge Biosciences (NBP) Asset Utilization Ratio (2022 - 2023) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Asset Utilization Ratio for 2 consecutive years, with 0.01 the latest figure, recorded in Q2 2023.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.01 (changed N/A YoY) and the FY2023 annual result came in at 0.0, down 37.19% from the prior year.
- Asset Utilization Ratio declined to 0.01 in Q2 2023 per NBP's latest filing, from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for NBP reached as high as 0.01 in Q4 2022 and fell as low as 0.01 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |